US$ 25.85
foxo4 dri peptide senolytic 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis foxo4-dri peptide senolytic 2024 study
Description
Lee et al., 2018)

& Tchkonia, T

Currently, there is no unified standard for senescence biomarkers [16]

A responsible program typically orders baseline labs before prescribing anything, so there is a clear starting picture and something to measure progress against
